10.76美元0.09(0.79%)
2025/05/22更新
績效 / 1月2.03%
3月7.54%
1年9.66%
晨星評等-
- 1.現金17.28%
- 2.股票14.49%
- 3.債券0.00%
- 4.其他68.23%
- 1.美國67.30%
- 2.歐洲不包含歐元區5.19%
- 3.日本4.96%
- 4.英國3.06%
- 5.大洋洲0.94%
- 1.Boston Scientific Corp8.46%
- 2.Vertex Pharmaceuticals Inc7.24%
- 3.Medtronic PLC7.07%
- 4.Intuitive Surgical Inc5.60%
- 5.Edwards Lifesciences Corp3.84%
- 6.Jazz Pharmaceuticals PLC3.73%
- 7.Alnylam Pharmaceuticals Inc3.42%
- 8.Roche Holding AG2.96%
- 9.SpringWorks Therapeutics Inc Ordinary Shares2.63%
- 10.Regeneron Pharmaceuticals Inc2.57%
- 1.現金17.28%
- 2.股票14.49%
- 3.債券0.00%
- 4.其他68.23%
- 1.美國67.30%
- 2.歐洲不包含歐元區5.19%
- 3.日本4.96%
- 4.英國3.06%
- 5.大洋洲0.94%
- 1.Boston Scientific Corp8.46%
- 2.Vertex Pharmaceuticals Inc7.24%
- 3.Medtronic PLC7.07%
- 4.Intuitive Surgical Inc5.60%
- 5.Edwards Lifesciences Corp3.84%
- 6.Jazz Pharmaceuticals PLC3.73%
- 7.Alnylam Pharmaceuticals Inc3.42%
- 8.Roche Holding AG2.96%
- 9.SpringWorks Therapeutics Inc Ordinary Shares2.63%
- 10.Regeneron Pharmaceuticals Inc2.57%